Atlas Arteria reports lapse of performance rights

Atlas Arteria has notified the market of the cessation of 24,464 unquoted performance rights, effective July 18, 2025. This cessation is attributed to the lapse of conditional rights to securities, as the stipulated conditions were either not met or became incapable of being satisfied. The company confirmed that no consideration was paid for this cessation. This notification pertains to rights that lapsed for the quarter ended September 30, 2025.

Following this change, the total number of unquoted performance rights on issue for Atlas Arteria stands at 2,598,103. The number of quoted ordinary shares remains unchanged at 1,450,833,707.

This announcement was made on October 14, 2025, and provides an update on the company's issued capital structure following the lapse of these conditional rights. The figures reported reflect the current state of Atlas Arteria's securities after this specific event, excluding any other changes currently pending ASX processing.